Related Experiment Video
Updated: Jul 2, 2026

Bioprospecting of Extremophilic Microorganisms to Address Environmental Pollution
Published on: December 30, 2021
Microbial N-demethylation: biotransformation and recovery of a drug metabolite
Brian L Davis1, Mark S Liu, Ronald L Hanson
1Process Research and Development, Bristol-Myers Squibb Co., New Brunswick, NJ 08903, USA.
Abstract:
A total of 39 microbes were screened for the ability to selectively N-demethylate (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1H-1,2,4-triazol-5-yl)aminopyrimidin-5-yl)-3,5-dihydroxy-hept-6-enoic acid (I), a potential drug for lowering blood cholesterol levels. Two Streptomyces species were found to carry out the desired N-demethylation. Bioconversion by Streptomyces griseus A.T.C.C. 13273 and product recovery were scaled up to the multi-gram level.
Related Concept Videos
Drug Biotransformation: Overview
Drug Biotransformation: Overview
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Microbial Bioremediation of Pesticides
Drug Metabolism: Phase II Reactions
Bioremediation

